- Standards of statin usage in Poland in high-risk patients: 3ST-POL study resultsDaniel Sliz
Medical University of Warsaw
Kardiol Pol 71:253-9. 2013..According to epidemiological studies, dyslipidaemia is the commonest risk factor of atherosclerosis in the Polish population. It is estimated that 18 million adult Poles are affected by dyslipidaemia...
- 3ST-POL trial: standards of statin use in Poland in the context of the European Society of Cardiology guidelinesDaniel Sliz
3rd Department of Internal Diseases and Cardiology, Medical University of Warsaw, Warszawa, Poland
Pol Arch Med Wewn 120:328-33. 2010..For the patient, as the beneficiary of an effective pharmacotherapy, it is of utmost importance that his or her physician can take maximum advantage of the whole potential of the available medications...
- Differences in achieving treatment goals with statin use in various regions of Poland - 3ST-POL study resultsDaniel Sliz
3rd Department of Internal Medicine and Cardiology, Medical University of Warsaw, Poland Public Health School, Centre of Postgraduate Medical Education, Poland
Ann Agric Environ Med 23:116-9. 2016..The purpose of this study was to evaluate regional differences in achieving treatment goals in total cholesterol (TC) and LDL cholesterol levels in patients treated with statins on an outpatient basis...